# Individual Product Bioequivalence Recommendations for Specific Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/individual-product-bioequivalence-recommendations-for-specific-products/321fabfb-8008-4b1d-856f-9a2e7d5e26b1

> FDA guidance document: Individual Product Bioequivalence Recommendations for Specific Products. Issue date: June 10, 2010. Get complete insights and analysis.

---

## Details

- Title: Individual Product Bioequivalence Recommendations for Specific Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2010-06-10
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2007-D-0433">FDA-2007-D-0433</a>

## Related Documents

- [End-of-Phase 2A Meetings](https://www.globalkeysolutions.net/guidances/guidance-document/end-of-phase-2a-meetings/05202b67-ba5f-49de-b49a-1f5466adf224)
- [Residual Solvents in Drug Products Marketed in the United States:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/residual-solvents-in-drug-products-marketed-in-the-united-states-guidance-for-industry/2d91b105-6b2c-4231-bcff-63a0d7fdc832)
- [ANDAs: Impurities in Drug Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/andas-impurities-in-drug-products-guidance-for-industry/1729c807-7b92-415c-a307-05a491b55e63)